ஷாத்துக்க் ஆய்வகங்கள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஷாத்துக்க் ஆய்வகங்கள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஷாத்துக்க் ஆய்வகங்கள் இன்க் Today - Breaking & Trending Today

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business .
Shattuck Labs, Inc.March 15, 2021 GMT
– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), expected in the second half of 2021 –
– Dose-escalation data from Phase 1 clinical trial for lead partnered PD-1 checkpoint inhibitor, SL-279252 (PD1-Fc-OX40L), expected in the second half of 2021 –
AUSTIN, TX and DURHAM, NC, March 15, 2021 (GLOBE NEWSWIRE) Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK ), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the fourth quarter and full year ended December 31, 2 ....

United States , North Carolina , Stephanie Ascher , Conor Richardson , Taylor Schreiber , Preclinical Development , Stern Investor Relations Inc , Society For Immunotherapy Of Cancer , Takeda Pharmaceuticals , Exchange Commission , Development Rd Expenses , American Association For Cancer Research , Shattuck Labs Inc , Truist Securities Life Sciences Summit , Agonist Redirected Checkpoint , Chief Executive Officer , Investigational New Drug , Gamma Deltat Cell Engager , Business Highlights , Ovarian Cancer , Skin Squamous Cell Carcinoma , Preclinical Introduction , Initial Public Offering , American Association , Cancer Research , Annual Oppenheimer Healthcare Conference ,

Shattuck Labs Added to Russell 2000® and 3000® Indexes


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Shattuck Labs Added to Russell 2000® and 3000® Indexes
Shattuck Labs, Inc.December 18, 2020 GMT
AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that it will be added to the Russell 2000® and 3000® Indexes effective December 21, 2020, following Russell’s quarterly additions of select initial public offerings.
“We are incredibly pleased to be included in the Russell 2000® and Russell 3000® Indexes,” said Andrew Neill, Shattuck’s Vice President of Finance and Corporate Strategy. “This milestone reflects the potential that investors see in Shattuck. Importantly, it increases our visibil ....

North Carolina , United States , Andrew Neill , Stephanie Ascher , Conor Richardson , Takeda Pharmaceuticals , Stern Investor Relations Inc , Shattuck Labs Inc , Vice President , Shattuck Labs , Agonist Redirected Checkpoint , Gamma Deltat Cell Engager , Investor Relations , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , ஆண்ட்ரூ நீல் , மாற்றாந்தாய் ஆஷர் , கோனார் ரிச்சர்ட்சன் , டாகேடா மருந்துகள் , கடுமையான முதலீட்டாளர் உறவுகள் இன்க் , ஷாத்துக்க் ஆய்வகங்கள் இன்க் , துணை ப்ரெஸிடெஂட் , ஷாத்துக்க் ஆய்வகங்கள் , முதலீட்டாளர் உறவுகள் ,